Generally, less leptin and ghrelin, and more of another compound, adiponectin, the less we eat
In line with reports indicating that PPAR may act on hypothalamic neurocircuitries 5,6 , we identified a series of new PPAR protein targets in the hypothalamus that are acutely upregulated by tesaglitazar and by GLP-1RA/tesaglitazar, but not by treatment with the GLP-1RA
Researchers have observed that patients prescribed semaglutide, the active ingredient in both drugs, had an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION)
The group called for stronger oversight where risks exist, transparency in sourcing and formulation (and) accountability for unsafe practices, while preserving access to legitimate compounding. Both Novo Nordisk, which makes semaglutide, the active ingredient in Wegovy
Do GLP-1 medications give you energy